Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

Here are four payer-related headlines in the last two weeks for ASCs to know. 1. Medical practices and hospitals saw claims denials increase and prior authorization denials decrease in 2024, according ...

FRGT: Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending WHLRL: Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending APVO: Trading Halt: Halted at 7:50: ...

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...